ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)

NCT00550745 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11999

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Zoster Vaccine, Live
BIOLOGICAL: Comparator: placebo

Sponsor

Merck Sharp & Dohme LLC